Signaling pathways
-
BA8929 HarringtonolideSummary: Harringtonolide is a potent inhibitor. - BA8930 NAMI-ASummary: NAMI-A is a ruthenium-based reagent.
- BA8931 FAK-IN-7Summary: FAK-IN-7 is an inhibitor (=11.72 μM).
- BA8932 FAK-IN-10Summary: FAK-IN-10 is an inhibitor.
- BA8933 H3B-6527Summary: H3B-6527 is an orally active, highly selective and covalent inhibitor <1.2 nM.
- BA8934 CYY292Summary: CYY292 is an inhibitor that specifically targets the FGFR1/AKT/Snail pathway in GBM cells.
- BA8935 FGFR-IN-1Summary: FGFR-IN-1 is a potent inhibitor.
- BA8936 RogaratinibSummary: Rogaratinib (BAY1163877) is a potent and selective inhibitor of the fibroblast growth factor receptor.
- BA8937 ODM-203Summary: ODM-203 is an orally effective, selective inhibitor.
- BA8938 ASP5878Summary: ASP5878 is an orally active, inhibitor of FGFR1, 2, 3, and 4 kinases with values of 0.47 nM, 0.6 nM, 0.74 nM, and 3.5 nM, respectively.